Results 251 to 260 of about 21,252 (310)

Telomeres at the nexus of aging, tumor suppression, and inflammation: toward an understanding beyond senescence. [PDF]

Genes Dev
Bloom SI, Karlseder J.
europepmc   +1 more source

Studying When to Add Biological Therapy to Cytotoxic Therapy in Advanced Cancer Care Using Real World Data: How to Avoid Design Choices That Generate Immortal Time

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Since real‐world data lack information on treatment assignment (usually the only information available is treatment prescription/administration) and early outcomes can happen in advanced cancer, some design choices may introduce immortal time due to selection or due to treatment strategy misclassification.
Xabier Garcia‐Albeniz, Julia Vila‐Guilera, Manuel Zamparini, Helena Oliveres, Vicente Alonso‐Orduna, Jaime Feliu, Ana Fernández‐Montes, Marta Martín‐Richard, Elisa Gálvez‐Munoz, Ana Ruiz‐Casado, Alfonso Yubero‐Esteban, Jorge Aparicio, Julia Alcaide‐Garcia, Javier Gallego Plazas, Carlos Fernandez‐Martos, Rosa Gallego‐Sanchez, Mónica Guillot Morales, Rubén Leno, Francis Esposito, Sandra Lopez‐Prades, Míriam Cuatrecasas, Barbra A. Dickerman, Joan Maurel   +22 more
wiley   +1 more source

Semaglutide and Cardiovascular Outcomes According to Baseline Aspirin Use: Analyses of the SOUL and SELECT Trials

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 6413-6416, July 2026.
Dirk Müller‐Wieland, Darren K. McGuire, A. Michael Lincoff, John B. Buse, Johannes F. E. Mann, Silvio E. Inzucchi, Rodica Pop‐Busui, Sharon L. Mulvagh, Scott S. Emerson, Neil R. Poulter, John E. Deanfield, Nikolaus Marx   +11 more
wiley   +1 more source

Retrospective Analysis of HER2 Testing, Treatment Patterns, and Clinical Outcomes in Patients With Locally Advanced or Metastatic NSCLC With HER2 Mutations in France

Cancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background HER2 (ERBB2) gene mutations are associated with poor prognosis in non‐small cell lung cancer (NSCLC). It is important to identify patients with HER2‐mutant (HER2m) NSCLC, as new targeted treatment options are emerging. However, HER2 testing in clinical practice varies across regions, and real‐world data on HER2m NSCLC are limited ...
Didier Debieuvre, Pauline Macouillard, Xavier Quantin, Mehmet Berktas, Nicolas Girard, Clarisse Audigier‐Valette, Thomas Filleron, Stefania Musilli, Lise Bosquet, Maurice Pérol   +9 more
wiley   +1 more source

Sleeping Spermatozoa: The Symbolism of Gamete Cryopreservation in the Context of Cancer in AYAs. [PDF]

Life (Basel)
Koscinski I, Mazzoleni C, Verhaeghe F, Klein JP, Ravel C.   +4 more
europepmc   +1 more source

Alternative Lengthening of Telomeres: A Prognostic Paradox in Cancer. [PDF]

Cells
Sung JY.
europepmc   +1 more source

The relationship between death anxiety and self-esteem: A protocol for a systematic review and meta-analysis. [PDF]

PLoS One
Connery T, Kukulite S, Farrell C, Horgan R, Barry K, Doyle M, Setti A, Murphy M.   +7 more
europepmc   +1 more source

Hallmarks of Cancer Expression in Oral Leukoplakia: A Scoping Review of Systematic Reviews and Meta-Analyses. [PDF]

Cancers (Basel)
González-Ruiz I, Samayoa-Descamps V, Guagua-Cortez KA, González-Moles MÁ, Ramos-García P.   +4 more
europepmc   +1 more source

Meaning in Life: Exploring the Potential of Mythological Narratives in Contemporary Life. [PDF]

Cult Med Psychiatry
Abazari N, Saarelainen SM.
europepmc   +1 more source